NCT06751056

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Neck Traction to Reduce Gabaergic Medication Use for Neuropathic Itch- A Pilot Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.

Conditions

• Pruritus

Interventions

Type	Name	Description
DEVICE	Cervical Traction Device	Participants will use their home neck traction devices daily for 12 weeks, while continuing their prescriptions for gabapentin or pregabalin. At study initiation and every 2 weeks thereafter for a total of 12 weeks, they will receive an electronic survey assessing their itch score. Based on survey results, they will receive a call from the study team to adjust their dosage of gabapentin or pregabalin by up to 33%.

Timeline

• Start date: 2025-06-01
• Primary completion: 2027-01-10
• Completion: 2027-01-10
• First posted: 2024-12-27
• Last updated: 2025-09-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study